The COVID-19 pandemic has had wide-ranging effects on the practice of medicine. Inside hospital walls, clinical teams scramble to address the influx of infected patients while infection prevention personnel work tirelessly to help contain the spread of the novel virus. These new procedures and protocols have significantly impacted radiology departments, practices, and imaging centers.
On Monday, May 4, 2020, Infection Control Today and Diagnostic Imaging hosted a joint webinar featuring experts in both radiology and infection prevention to review the latest disinfection guidelines across key radiology modalities, examine how radiologists are adapting their workflows, and explore plans for how to best emerge, both clinically and financially, from this pandemic.
Panelists:
Mahmud Mossa-Basha, MD, DABR
Dr. Mossa-Basha is an associate professor of radiology at the University of Washington (UW) and a neuroradiologist in the Department of Radiology at the UW Medical Center. His clinical and research areas of expertise include cerebrovascular imaging, vessel wall imaging of multiple vascular beds, atherosclerosis and vasculitis imaging and susceptibility weighted imaging. In addition, Dr. Mossa-Basha has an interest in advanced imaging of the spine. Dr. Mossa-Basha serves as the director of cross-sectional neurovascular imaging at UW and Harborview Medical Center and is the co-director of intravenous contrast policy.
Dhruv Chopra, MBA
As Chief Executive Officer, Dhruv Chopra presides over Collaborative Imaging and their respective divisions. He previously spent 15 years as an executive with multiple billing companies in the radiology industry where he gained an appreciation for how much physician money is lost due to the inefficiencies with data gathering, claim submission and adjudication, documentation, charge capture and coding, and the dynamic, ever-changing requirements of insurance carriers. Unable to tolerate the revenue losses that physicians were facing, the blatant workflow inefficiencies that plague every radiology practice, Chopra created his own path to combat these obstacles with the formation of Collaborative Imaging.
Saskia v. Popescu, PhD, MPH, MA, CIC
Dr. Saskia Popescu is an infectious disease epidemiologist and infection preventionist with a focus on hospital biopreparedness and the role of infection prevention in health security efforts. She is an expert in healthcare biopreparedness and is nationally recognized for her work to build hospital response to infectious diseases events. She holds a PhD in Biodefense from George Mason University, a Masters in Public Health with a focus on infectious diseases, and a Masters of Arts in International Security Studies, from the University of Arizona. Saskia is a 2017 fellow of the Johns Hopkins Center for Health Security Emerging Leaders in Biosecurity Initiative (ELBI), an external expert for the European Centre for Disease Control (ECDC), and a recipient of the Presidential Scholarship at George Mason University.
“Ongoing Assault”: How HHS Layoffs Have Eviscerated Infection Prevention Support Across the Nation
April 1st 2025Mass layoffs at HHS and CDC have gutted critical infection prevention programs, leaving frontline professionals overwhelmed, under-resourced, and desperate to safeguard public health.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.